The Center for Disease Control is offering a grant to monitor respiratory syncytial virus (RSV) and other viral infections among Native American and Alaska Native populations. RSV is a significant cause of lower respiratory infections in infants, particularly affecting Native American children. With numerous RSV prevention products in development, this grant aims to establish baseline data on infection burden and continue post-licensure surveillance. Additionally, severe respiratory infections linked to human metapneumovirus and other viruses will be tracked. This funding opportunity will help assess and address the impact of these infections in high-risk populations.
Opportunity ID: 308248
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-19-001 |
| Funding Opportunity Title: | Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 29, 2018 |
| Last Updated Date: | Oct 29, 2018 |
| Original Closing Date for Applications: | Feb 01, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Feb 01, 2019 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 03, 2019 |
| Estimated Total Program Funding: | $5,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $750,000 |
Eligibility
| Eligible Applicants: | County governments City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Independent school districts Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Additional Information on Eligibility: For-profit institutions are not eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | Respiratory syncytial virus (RSV) is the leading viral cause of lower respiratory tract infection including bronchiolitis and pneumonia in infants and children worldwide. The annual rate of RSV hospitalizations for children less than 2 years of age in the US is 5.2 per 1,000, but substantially higher among Native Americans. There are currently approximately 40 vaccines or antibody products in development designed to prevent RSV infections. With potential licensure of these products on the horizon, it will be important to establish baseline estimates of the burden of RSV infections in high-risk populations, like Native Americans, and to maintain surveillance post-licensure in order to evaluate impact. Native Americans are also at higher risk for severe respiratory infections associated with human metapneumovirus (HMPV) and other viruses, which will also be monitored through this system. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Amy Yang
vdz9@cdc.gov Email:vdz9@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 308248 Full Announcement-NOFO Full Announcement -> RFA-IP-19-001 Final NOFO.pdf
Folder 308248 Other Supporting Documents-SF-424 R&R Instructions -> General Instuctions for NIH and Other PHS Agencies.pdf
Packages
| Agency Contact Information: | Amy Yang vdz9@cdc.gov Email: vdz9@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.185 | RFA-IP-19-001 | Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaska Natives | PKG00245943 | Oct 29, 2018 | Feb 01, 2019 | View |
Package 1
Mandatory forms
308248 RR_SF424_2_0-2.0.pdf
308248 PHS398_CoverPageSupplement_4_0-4.0.pdf
308248 RR_OtherProjectInfo_1_4-1.4.pdf
308248 PerformanceSite_2_0-2.0.pdf
308248 RR_KeyPersonExpanded_2_0-2.0.pdf
308248 RR_Budget_1_4-1.4.pdf
308248 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308248 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
